Literature DB >> 17823986

EMR1, the human homolog of F4/80, is an eosinophil-specific receptor.

Jörg Hamann1, Nathalie Koning, Walter Pouwels, Laurien H Ulfman, Marco van Eijk, Martin Stacey, Hsi-Hsien Lin, Siamon Gordon, Mark J Kwakkenbos.   

Abstract

The EGF-TM7 F4/80 is a defining marker of murine macrophage populations. Applying flow cytometric analysis using the newly generated mAb A10, and quantitative real-time PCR, we here report the surprising observation that the human ortholog of F4/80, EGF-like module containing mucin-like hormone receptor (EMR)1, is absent on mononuclear phagocytic cells including monocytes, macrophages, and myeloid dendritic cells. Unexpectedly, we found that EMR1 expression is restricted to eosinophilic granulocytes, where expression is overlapping with the eotaxin receptor CCR3 and the immunoglobulin-like lectin Siglec-8. Absence on other leukocytes, including basophils, implies that EMR1 is a highly specific marker for eosinophils in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823986     DOI: 10.1002/eji.200737553

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  69 in total

Review 1.  [Old immune system- new information? Importance of mononuclear phagocytes in corneal allograft rejection].

Authors:  T Lapp; D Reinhold; P Maier; T Reinhard
Journal:  Ophthalmologe       Date:  2012-09       Impact factor: 1.059

2.  Gene transcription abnormalities in canine atopic dermatitis and related human eosinophilic allergic diseases.

Authors:  Douglas A Plager; Sheila M F Torres; Sandra N Koch; Hirohito Kita
Journal:  Vet Immunol Immunopathol       Date:  2012-06-12       Impact factor: 2.046

3.  Mass cytometry deep phenotyping of human mononuclear phagocytes and myeloid-derived suppressor cells from human blood and bone marrow.

Authors:  Mikael Roussel; P Brent Ferrell; Allison R Greenplate; Faustine Lhomme; Simon Le Gallou; Kirsten E Diggins; Douglas B Johnson; Jonathan M Irish
Journal:  J Leukoc Biol       Date:  2017-04-11       Impact factor: 4.962

4.  Mutant SOD1 G93A microglia have an inflammatory phenotype and elevated production of MCP-1.

Authors:  Siranush A Sargsyan; Daniel J Blackburn; Siân C Barber; Peter N Monk; Pamela J Shaw
Journal:  Neuroreport       Date:  2009-10-28       Impact factor: 1.837

Review 5.  Biologic therapies targeting eosinophils: current status and future prospects.

Authors:  Fanny Legrand; Amy D Klion
Journal:  J Allergy Clin Immunol Pract       Date:  2015 Mar-Apr

Review 6.  Diagnosis and Novel Approaches to the Treatment of Hypereosinophilic Syndromes.

Authors:  Melanie C Dispenza; Bruce S Bochner
Journal:  Curr Hematol Malig Rep       Date:  2018-06       Impact factor: 3.952

7.  Identification of a murine CD45-F4/80lo HSC-derived marrow endosteal cell associated with donor stem cell engraftment.

Authors:  Kathleen M Overholt; Satoru Otsuru; Timothy S Olson; Adam J Guess; Victoria M Velazquez; Laura Desbourdes; Massimo Dominici; Edwin M Horwitz
Journal:  Blood Adv       Date:  2017-12-14

Review 8.  Eosinophils and Macrophages within the Th2-Induced Granuloma: Balancing Killing and Healing in a Tight Space.

Authors:  Anupama Ariyaratne; Constance A M Finney
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.441

Review 9.  Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.

Authors:  B S Bochner
Journal:  Clin Exp Allergy       Date:  2009-03       Impact factor: 5.018

10.  Gene transcription changes in asthmatic chronic rhinosinusitis with nasal polyps and comparison to those in atopic dermatitis.

Authors:  Douglas A Plager; Jane C Kahl; Yan W Asmann; Allan E Nilson; John F Pallanch; Oren Friedman; Hirohito Kita
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.